Time: 8:00 AM PT, 10:00 AM CT, 11:00 AM ET, 3:00 PM GMT, 4:00 PM CET, 5:00 PM EET Abstract You don’t have to miss the innovation because you missed the conference ...
There are two key things to know about the new Applied Biosystemsâ„¢ SwiftArrayStudioâ„¢ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research WALTHAM, Mass.--(BUSINESS WIRE) ...
NEW YORK – Thermo Fisher Scientific, Genovation Health, and XYGene have signed a multiyear comarketing collaboration agreement aimed at expanding access to integrated genomic solutions, the firms ...
This narrative review reports recent advances in transfusion medicine, encompassing enhancements in molecular diagnostics, blood engineering, and therapeutic technologies. It summarizes findings from ...
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for HER2-Amplified Advanced Biliary Tract Cancer Among 667 patients with both baseline ctDNA ...
SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
This study aims to evaluate the utility of polygenic risk scores (PRS) in women with early menopause (EM) and to investigate the clinical characteristics and risk factors associated with EM based on ...
As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results